A federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma’s settlement of thousands of legal claims over the toll of opioids.
Thank you for supporting our journalism. This article is available exclusively for our subscribers, who help fund our work at the Chicago Tribune.Jayde Newton helps to set up cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y., on Aug. 9, 2021.
Under the plan, members of the Sackler family would give up ownership of Stamford, Connecticut-based Purdue, which would become a new company known as Knoa, with its profits being used to fight the opioid crisis. They would also contribute $5.5 billion to $6 billion in cash over time. A chunk of that money — at least $750 million — is to go to individual victims of the opioid crisis and their survivors.
A lawyer from that office told the 2nd Circuit in April 2022 that it’s a “fundamental inconsistency” that people who do not seek bankruptcy protection and have to give up most of their assets could be exempted from some lawsuits.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsA federal court ruling cleared the way Tuesday for OxyContin maker Purdue Pharma’s settlement of thousands of legal claims over the toll of opioids.
Consulte Mais informação »
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsRuling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits Sackler family members have been clear: If they don’t get the legal protections, they won’t do their part of the deal
Consulte Mais informação »
Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuitsA federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids
Consulte Mais informação »
Court Protects Sacklers From Opioid Lawsuits In Purdue Settlement DealA federal court ruled Tuesday to shield members of the Sackler family—which owns OxyContin producer Purdue Pharma—from any future civil lawsuits over their company’s ties to the opioid addiction crisis
Consulte Mais informação »
Purdue Pharma can protect Sackler owners in opioid bankruptcy, court rulesBankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company's broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday.
Consulte Mais informação »
North Korea to hold key ruling party meeting in early JuneNorth Korea's ruling party will hold a key meeting in early June to review the country's economic plans, state media KCNA reported on Monday.
Consulte Mais informação »